My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    Error occurred: cannot get document summary

    PMID:
    22287684

    2.

    About locoregional recurrence risk after lipofilling in breast cancer patients.

    Semprini G, Cattin F, Lazzaro L, Cedolini C, Parodi PC.

    Ann Oncol. 2012 Mar;23(3):802-3; author reply 803-4. Epub 2012 Jan 23. No abstract available.

    PMID:
    22269177
    [PubMed - in process]

    Related citations

    3.

    Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer.

    Andre F, Conforti R, Moeder CB, Mauguen A, Arnedos M, Berrada N, Delaloge S, Tomasic G, Spielmann M, Esteva FJ, Rimm DL, Michiels S.

    Ann Oncol. 2012 Jan 11. [Epub ahead of print]

    PMID:
    22241898
    [PubMed - as supplied by publisher]

    Related citations

    4.

    Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies.

    Aune D, Chan DS, Greenwood DC, Vieira AR, Rosenblatt DA, Vieira R, Norat T.

    Ann Oncol. 2012 Jun;23(6):1394-402. Epub 2012 Jan 10.

    PMID:
    22234738
    [PubMed - in process]

    Related citations

    5.

    Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified?

    Buggi F, Folli S, Curcio A, Casadei-Giunchi D, Rocca A, Pietri E, Medri L, Serra L.

    Ann Oncol. 2012 Jan 4. [Epub ahead of print]

    PMID:
    22219015
    [PubMed - as supplied by publisher]

    Related citations

    6.

    PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.

    Jensen JD, Knoop A, Laenkholm AV, Grauslund M, Jensen MB, Santoni-Rugiu E, Andersson M, Ewertz M.

    Ann Oncol. 2011 Dec 15. [Epub ahead of print]

    PMID:
    22172323
    [PubMed - as supplied by publisher]

    Related citations

    7.

    Screening mammography and socioeconomic inequalities in breast cancer survival.

    Woods LM, Sasieni P, Rachet B.

    Ann Oncol. 2012 Feb;23(2):285-6. Epub 2011 Dec 9. No abstract available.

    PMID:
    22156623
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.

    He X, Esteva FJ, Ensor J, Hortobagyi GN, Lee MH, Yeung SC.

    Ann Oncol. 2011 Nov 22. [Epub ahead of print]

    PMID:
    22112968
    [PubMed - as supplied by publisher]

    Related citations

    9.

    Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy.

    Mathieu MC, Mazouni C, Kesty NC, Zhang Y, Scott V, Passeron J, Arnedos M, Schnabel CA, Delaloge S, Erlander MG, André F.

    Ann Oncol. 2011 Nov 22. [Epub ahead of print]

    PMID:
    22112967
    [PubMed - as supplied by publisher]

    Related citations

    10.

    Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects.

    Pemmaraju N, Munsell MF, Hortobagyi GN, Giordano SH.

    Ann Oncol. 2012 Jun;23(6):1471-4. Epub 2011 Nov 15.

    PMID:
    22085764
    [PubMed - in process]

    Related citations

    11.

    Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines.

    Collins DM, O'Donovan N, McGowan PM, O'Sullivan F, Duffy MJ, Crown J.

    Ann Oncol. 2011 Nov 5. [Epub ahead of print]

    PMID:
    22056974
    [PubMed - as supplied by publisher]

    Related citations

    12.

    Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study.

    Psyrri A, Kalogeras KT, Kronenwett R, Wirtz RM, Batistatou A, Bournakis E, Timotheadou E, Gogas H, Aravantinos G, Christodoulou C, Makatsoris T, Linardou H, Pectasides D, Pavlidis N, Economopoulos T, Fountzilas G.

    Ann Oncol. 2012 Jun;23(6):1422-7. Epub 2011 Nov 4.

    PMID:
    22056852
    [PubMed - in process]

    Related citations

    13.

    Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.

    Romero A, Martín M, Oliva B, de la Torre J, Furio V, de la Hoya M, García-Sáenz JA, Moreno A, Román JM, Diaz-Rubio E, Caldés T.

    Ann Oncol. 2011 Nov 2. [Epub ahead of print]

    PMID:
    22052985
    [PubMed - as supplied by publisher]

    Related citations

    14.

    Validation of a predictive model that identifies patients at high risk of developing febrile neutropaenia following chemotherapy for breast cancer.

    Jenkins P, Scaife J, Freeman S.

    Ann Oncol. 2011 Nov 2. [Epub ahead of print]

    PMID:
    22048149
    [PubMed - as supplied by publisher]

    Related citations

    15.

    An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer.

    Danese MD, O'Malley C, Lindquist K, Gleeson M, Griffiths RI.

    Ann Oncol. 2011 Oct 29. [Epub ahead of print]

    PMID:
    22039090
    [PubMed - as supplied by publisher]

    Related citations

    16.

    Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer.

    Gori S, Montemurro F, Spazzapan S, Metro G, Foglietta J, Bisagni G, Ferzi A, Silva RR, Gamucci T, Clavarezza M, Stocchi L, Fabi A, Cognetti F, Torrisi E, Crivellari D.

    Ann Oncol. 2012 Jun;23(6):1436-41. Epub 2011 Oct 29.

    PMID:
    22039084
    [PubMed - in process]

    Related citations

    17.

    Outcome of special types of luminal breast cancer.

    Colleoni M, Rotmensz N, Maisonneuve P, Mastropasqua MG, Luini A, Veronesi P, Intra M, Montagna E, Cancello G, Cardillo A, Mazza M, Perri G, Iorfida M, Pruneri G, Goldhirsch A, Viale G.

    Ann Oncol. 2012 Jun;23(6):1428-36. Epub 2011 Oct 29.

    PMID:
    22039080
    [PubMed - in process]

    Related citations

    18.

    Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up.

    Haest K, Kumar A, Van Calster B, Leunen K, Smeets A, Amant F, Berteloot P, Wildiers H, Paridaens R, Van Limbergen E, Weltens C, Janssen H, Peeters S, Menten J, Vergote I, Morlion B, Verhaeghe J, Christiaens MR, Neven P.

    Ann Oncol. 2012 Jun;23(6):1449-54. Epub 2011 Oct 29.

    PMID:
    22039079
    [PubMed - in process]

    Related citations

    19.

    Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07).

    Zaman K, Thürlimann B, Huober J, Schönenberger A, Pagani O, Lüthi J, Simcock M, Giobbie-Hurder A, Berthod G, Genton C, Brauchli P, Aebi S; on behalf of the Swiss Group for Clinical Cancer Research (SAKK).

    Ann Oncol. 2012 Jun;23(6):1474-1481. Epub 2011 Oct 14.

    PMID:
    22003243
    [PubMed - as supplied by publisher]

    Related citations

    20.

    Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic.

    Syed BM, Johnston SJ, Wong DW, Green AR, Winterbottom L, Kennedy H, Simpson N, Morgan DA, Ellis IO, Cheung KL.

    Ann Oncol. 2012 Jun;23(6):1465-71. Epub 2011 Oct 14.

    PMID:
    22003241
    [PubMed - in process]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk